Medication treatment strategies in the MTA study: Relevance to clinicians and researchers Article

Greenhill, LL, Abikoff, HB, Arnold, LE et al. (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers . JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 35(10), 1304-1313. 10.1097/00004583-199610000-00017

Open Access International Collaboration

cited authors

  • Greenhill, LL; Abikoff, HB; Arnold, LE; Cantwell, DP; Conners, CK; Elliott, G; Hechtman, L; Hinshaw, SP; Hoza, B; Jensen, PS; March, JS; Newcorn, J; Pelham, WE; Severe, JB; Swanson, JM; Vitiello, B; Wells, K

sustainable development goals

publication date

  • October 1, 1996

keywords

  • ADHD
  • ADOLESCENTS
  • DEFICIT HYPERACTIVITY DISORDER
  • DEXTROAMPHETAMINE
  • DRUG RESPONSE
  • HYPERKINETIC-CHILDREN
  • Life Sciences & Biomedicine
  • PSYCHIATRY
  • PSYCHOTHERAPY-RESEARCH
  • Pediatrics
  • Psychiatry
  • Psychology
  • Psychology, Developmental
  • STIMULANTS
  • SUSTAINED-RELEASE METHYLPHENIDATE
  • Science & Technology
  • Social Sciences
  • attention-deficit hyperactivity disorder
  • dextroamphetamine
  • imipramine
  • methylphenidate
  • multisite trial
  • pemoline

Digital Object Identifier (DOI)

publisher

  • WILLIAMS & WILKINS

start page

  • 1304

end page

  • 1313

volume

  • 35

issue

  • 10